These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27122322)

  • 1. Now you see me, now you don't: The case of a vanishing outflow gradient in a patient with hypertrophic cardiomyopathy.
    Corrigan FE; Douglas JS
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):1006-1009. PubMed ID: 27122322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: An Echocardiography and Cardiovascular Magnetic Resonance Imaging Study.
    Lu M; Du H; Gao Z; Song L; Cheng H; Zhang Y; Yin G; Chen X; Ling J; Jiang Y; Wang H; Li J; Huang J; He Z; Zhao S
    Circ Cardiovasc Interv; 2016 Mar; 9(3):e002675. PubMed ID: 26884612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.
    Shelke AB; Menon R; Kapadiya A; Yalagudri S; Saggu D; Nair S; Narasimhan C
    Indian Heart J; 2016; 68(5):618-623. PubMed ID: 27773399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
    Lafitte S; Reant P; Touche C; Pillois X; Dijos M; Arsac F; Peyrou J; Montaudon M; Ritter P; Roudaut R; Demaria A
    J Am Coll Cardiol; 2013 Aug; 62(9):842-50. PubMed ID: 23810875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol septal ablation in patients with concomitant hypertrophic cardiomyopathy and aortic valvular stenosis.
    El-Sabawi B; Nishimura RA; Guerrero ME; Rihal CS; Eleid MF
    Catheter Cardiovasc Interv; 2020 Mar; 95(4):830-837. PubMed ID: 31410979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes.
    Desai MY; Bhonsale A; Patel P; Naji P; Smedira NG; Thamilarasan M; Lytle BW; Lever HM
    JACC Cardiovasc Imaging; 2014 Jan; 7(1):26-36. PubMed ID: 24290569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic changes in systolic and diastolic function during isoproterenol challenge predicts symptomatic response to myectomy in hypertrophic cardiomyopathy with labile obstruction.
    Prasad M; Geske JB; Sorajja P; Ommen SR; Schaff HV; Gersh BJ; Nishimura RA
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):962-970. PubMed ID: 27062082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Septal Reduction on Left Atrial Size and Diastole in Hypertrophic Cardiomyopathy.
    Finocchiaro G; Haddad F; Kobayashi Y; Lee D; Pavlovic A; Schnittger I; Sinagra G; Magavern E; Myers J; Froelicher V; Knowles JW; Ashley E
    Echocardiography; 2016 May; 33(5):686-94. PubMed ID: 26926154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of coil embolization of the septal perforator for septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Guerrero I; Dhoble A; Fasulo M; Denktas AE; Sami S; Choi S; Balan P; Arain SA; Smalling RW
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):971-977. PubMed ID: 27511120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Outcome of Alcohol Septal Ablation With Confirmation by Nitroglycerin Test for Drug-Refractory Hypertrophic Obstructive Cardiomyopathy With Labile Left Ventricular Outflow Obstruction.
    Kitamura M; Takayama M; Matsuda J; Kubota Y; Nakamura S; Takano H; Asai K; Shimizu W
    Am J Cardiol; 2015 Sep; 116(6):945-51. PubMed ID: 26209114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy.
    Fortunato de Cano S; Nicolas Cano M; de Ribamar Costa J; Alves Pinheiro J; Bellio de Mattos Barretto R; Costa de Souza Le Bihan D; Abizaid A; Sousa A; Eduardo Sousa J
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):953-960. PubMed ID: 27143093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of immediate decrease in ventricular septal strain after alcohol septal ablation for obstructive hypertrophic cardiomyopathy to long-term reduction in left ventricular outflow tract pressure gradient.
    van Ramshorst J; Mollema SA; Delgado V; van der Wall EE; Schalij MJ; Atsma DE; Bax JJ
    Am J Cardiol; 2009 Jun; 103(11):1592-7. PubMed ID: 19463521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
    Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Takotsubo cardiomyopathy in a patient with previously undiagnosed hypertrophic cardiomyopathy with obstruction.
    Brabham WW; Lewis GF; Bonnema DD; Nielsen CD; O'Brien TX
    Cardiovasc Revasc Med; 2011; 12(1):70.e1-5. PubMed ID: 21036671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular energetics in patients with hypertrophic cardiomyopathy and the effect of alcohol septal ablation.
    Timmer SA; Knaapen P; Germans T; Lubberink M; Dijkmans PA; Vonk-Noordegraaf A; Ten Berg JM; Ten Cate FJ; Lammertsma AA; van Rossum AC
    J Card Fail; 2011 Oct; 17(10):827-31. PubMed ID: 21962421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitral stenosis and hypertrophic obstructive cardiomyopathy: An unusual combination.
    Hong J; Schaff HV; Ommen SR; Abel MD; Dearani JA; Nishimura RA
    J Thorac Cardiovasc Surg; 2016 Apr; 151(4):1044-8. PubMed ID: 26724969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to significant gradient reduction following septal balloon occlusion predicts the magnitude of final gradient response during alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Almasood A; Garceau P; Woo A; Rakowski H; Schwartz L; Overgaard CB
    JACC Cardiovasc Interv; 2011 Sep; 4(9):1030-4. PubMed ID: 21939945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of septal myectomy on left atrial volume and left ventricular diastolic filling patterns: an echocardiographic study of young patients with obstructive hypertrophic cardiomyopathy.
    Menon SC; Ackerman MJ; Ommen SR; Cabalka AK; Hagler DJ; O'Leary PW; Dearani JA; Cetta F; Eidem BW
    J Am Soc Echocardiogr; 2008 Jun; 21(6):684-8. PubMed ID: 18187287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of dobutamine stress echocardiography and exercise echocardiography in evaluating left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy].
    Shao CL; Duan FJ; Qiao SB; You SJ; Hu FH; Yuan JS; Yang WX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Mar; 40(3):214-8. PubMed ID: 22801266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent obstruction and left atrial size are predictors of clinical deterioration leading to septal reduction in hypertrophic cardiomyopathy.
    Finocchiaro G; Haddad F; Pavlovic A; Sinagra G; Schnittger I; Knowles JW; Perez M; Magavern E; Myers J; Ashley E
    J Card Fail; 2014 Apr; 20(4):236-43. PubMed ID: 24486928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.